Carteolol ophthalmic Interactions
There are 217 drugs known to interact with carteolol ophthalmic, along with 9 disease interactions. Of the total drug interactions, 28 are major, 186 are moderate, and 3 are minor.
- View all 217 medications that may interact with carteolol ophthalmic
- View carteolol ophthalmic disease interactions (9)
Most frequently checked interactions
View interaction reports for carteolol ophthalmic and the medicines listed below.
- Acetylsalicylic Acid (aspirin)
- Acidophilus (lactobacillus acidophilus)
- Aleve (naproxen)
- Aricept (donepezil)
- Aspirin Low Strength (aspirin)
- Benadryl (diphenhydramine)
- CoQ10 (ubiquinone)
- Flonase (fluticasone nasal)
- Incruse Ellipta (umeclidinium)
- Lumigan (bimatoprost ophthalmic)
- Metamucil (psyllium)
- Milk of Magnesia (magnesium hydroxide)
- MiraLAX (polyethylene glycol 3350)
- PreserVision AREDS 2 (multivitamin with minerals)
- Prilosec (omeprazole)
- Remeron (mirtazapine)
- Seroquel (quetiapine)
- Simbrinza (brimonidine / brinzolamide ophthalmic)
- Symbicort (budesonide / formoterol)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vyzulta (latanoprostene bunod ophthalmic)
- Xalatan (latanoprost ophthalmic)
- Xanax (alprazolam)
- Xyzal Allergy 24HR (levocetirizine)
- Zyrtec (cetirizine)
Carteolol ophthalmic disease interactions
There are 9 disease interactions with carteolol ophthalmic which include:
- asthma/COPD
- bradycardia/AV block
- cardiogenic shock
- CHF
- diabetes
- hypersensitivity
- hyperthyroidism
- PVD
- myasthenia gravis
Report options
QR code containing a link to this page
More about carteolol ophthalmic
- carteolol ophthalmic consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- Drug class: ophthalmic glaucoma agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.